C4X Discovery agrees licensing deal with Sanofi
Sanofi could pay up to €414m for C4X Discovery’s oral IL-17A inhibitor programme
Read More
Tag: C4X Discovery
C4XD forms discovery partnership with AI company GTN
C4X Discovery has entered into a drug discovery partnership with artificial intelligence (AI) company GTN.
Read More
- CERo reports encouraging early data from phase 1 trial of CER‑1236
- ENA Respiratory begins dosing in phase 2 study of INNA‑051 nasal spray
- Argo Biopharma doses first patient in phase 2b trial of BW‑20829
- Akari files new patent and advances second ADC targeting CEACAM5
- BioMed X launches kidney disease project in partnership with the government of Barbados
